Latest Data Demonstrate Boehringer Ingelheim’s Pramipexole …PharmaLive.com (press release), PA - 34 minutes ago… Pramipexole (known in Europe under the trade names Sifrol® and Mirapexin® and in the USA as Mirapex®) is a compound from Boehringer Ingelheim research first …
Read full story
Boehringer Ingelheim's Pramipexole (Mirapexin(R)/Sifrol(R)) Shown …news aktuell (Pressemitteilung), Germany - 6 hours ago… known in Europe under the trade names Sifrol(R) and Mirapexin(R) and in the USA as Mirapex(R)) is a compound from Boehringer Ingelheim research first licensed … Boehringer Ingelheim's Pramipexole (Mirapexin(R)/Sifrol(R)) Shown … FinanzNachrichten.deall 4 news articles
Read full story
Market Report — In Play (TEAM)MSN Money - 7 hours agoTechTeam awarded three-year contract for IT support services from Boehringer Ingelheim UK Co announces it has been chosen by Boehringer Ingelheim, to deliver a … TechTeam Global Receives 3-year Contract For IT Support Services … Trading MarketsTechTeam Global Awarded Three-Year Contract for IT Support … Yahoo! News (press release)TechTeam Global Awarded Three-Year Contract for IT Support … Earthtimes.orgall 5 news articles
Read full story
Largest-Ever Secondary Stroke Prevention Trial Completes …Medical News Today (press release), UK - Oct 27, 2006PRoFESS aims to demonstrate that extended release dipyridamole plus ASA[x], marketed by Boehringer Ingelheim as Aggrenox(R) or Asasantin(R)Retard , is superior …
Read full story
Boehringer Ingelheim: Unfounded Fear of Addiction Prevents …Juraforum.de, Germany - Oct 25, 2006… For more information on UEGW, visit www.uegw2006.de/. The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. …
Read full story
out of 4 Filipino suffer from constipationINQ7.net, Philippines - 22 hours ago… The 2000 Usage and Attitude Studies among 500 Filipino sufferers of constipation by pharmaceutical company Boehringer Ingelheim was revealed recently at a …
Read full story
PROTEST: Boehringer defends animal treatment in wake of small …Ridgefield Press, USA - 2 hours ago… “Boehringer-Ingelheim is one of the sloppiest labs in the country,” Mr. Budkie said. “They don’t follow any of the protocols …
Read full story
Largest-Ever Secondary Stroke Prevention Trial Completes …Yahoo! News (press release) - 9 hours agoPRoFESS aims to demonstrate that extended release dipyridamole plus ASA[x], marketed by Boehringer Ingelheim as Aggrenox® or Asasantin®Retard , is superior … Largest-Ever Secondary Stroke Prevention Trial Completes … Earthtimes.orgLargest-Ever Secondary Stroke Prevention Trial Completes … PR Newswire (press release)Largest-Ever Secondary Stroke Prevention Trial Completes … netPR.pl (komunikaty prasowe)all 5 news articles
Read full story
The Nose KnowsTherapeutics Daily (subscription) (press release), PA - 11 hours ago… Dr. Phillips serves on the speaker's bureau of Cephalon, Boehringer Ingelheim, Merck, ResMed, and GlaxoSmithKline, and is a consultant for Boehringer Ingelheim …
Read full story
Basketball Legend Earl 'The Pearl' Monroe to Be in Harlem to …Yahoo! News (press release) - Oct 25, 2006… This "One Week Challenge" campaign is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. … Boehringer Ingelheim Pharmaceuticals, Inc. …
Read full story
Basketball Legend Earl 'The Pearl' Monroe to Be in Harlem to …PR Newswire (press release), NY - 10 hours ago… This "One Week Challenge" campaign is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. … Boehringer Ingelheim Pharmaceuticals, Inc. …
Read full story
Boehringer Ingelheim: Unfounded Fear of Addiction Prevents …Earthtimes.org - 2 hours ago… The Boehringer Ingelheim group is one of the world's 20 leadingpharmaceutical companies. … For more information, visitwww.boehringer-ingelheim.com. … Boehringer Ingelheim: Unfounded Fear of Addiction Prevents … campus medall 8 news articles
Read full story
APHIS approves new Boehringer Ingelheim circovirus vaccineAgriculture Online - 9 hours agoBoehringer Ingelheim Vetmedica, Inc., (BIVI) announced this week that it has received approval from the US Animal and Plant Health Inspection Service for a new …
Read full story
Inflammatory Markers Refine Prognosis After StrokeMedPage Today, NJ - 2 hours ago… Dr. Elkind received honoraria for speaking form BMS-Sanofi Pharmaceutical Partnership, Boehringer-Ingelheim, Inc., and diaDexus as well as research support …
Read full story
Boehringer set to acquire Zantac medicationFairfield County Business Journal, NY - 7 hours agoBy BOB CHUVALA. Boehringer Ingelheim Pharmaceuticals Inc. has agreed to acquire the US rights to Zantac from Pfizer Inc. for $509.5 million in cash. …
Read full story
SCIENCE 2006: TOP EMPLOYER SURVEY: It All Starts with ScienceScienceCareers.org, DC - 3 hours ago… Boehringer Ingelheim rises to second place this year, after finishing eighth in 2005. Roche Pharmaceuticals also climbs six places, from ninth to third. …
Read full story
Abbott profit rises on strong drug salesReuters - 20 hours ago… The drugs, including arthritis treatment Mobic, had been sold by Abbott under a long-term arrangement with German drugmaker Boehringer Ingelheim that ended in … Abbott Labs' Profit Rises 5.2% Wall Street Journal (subscription)Abbott posts moderately higher profit MarketWatchEarnings Climb 5% at Abbott Laboratories New York TimesHouston Chronicleall 116 news articles
Read full story
Professor Terrence Forrester is Announced as Winner of the …PharmaLive.com (press release), PA - 10 hours ago18 2006 - The Boehringer Ingelheim Developing World Award has been presented to Professor Terrence Forrester, currently Professor of Medicine at the University …
Read full story
Abbott Puts Its Money on the Table: Fool by NumbersMotley Fool - 5 hours ago… Gross margins improved in comparison with last year, primarily because of the discontinuation of sales from the Boehringer Ingelheim distribution deal. …
Read full story
Abbott posts moderately higher profitMarketWatch - 28 minutes ago… The quarter also reflected the absence of revenue from three drugs Abbott had sold in the past for German drugmaker Boehringer Ingelheim: Mobic, Flomax and … Abbott Reports Strong Third-Quarter Results, Announces $2.5 … Yahoo! News (press release)Abbott's Net Rises 5 Percent on Humira, Device Sales (Update2) Bloombergall 11 news articles
Read full story